Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC28H47N7O14 |
InChIKeyDUORKVZYABUEHW-AHJYMZSGSA-N |
CAS Registry1851348-04-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | - |